CEU Course: An Introduction to Pathogen Reduction

Pathogen reduction has been recently approved for use in the United States and blood bankers as well as physicians who order blood components need to become familiar with these concepts. This course provides an introduction to currently available systems for plasma and platelets, the history of pathogen reduction and some of the challenges to adopting these technologies.

TARGET AUDIENCE/PRE-REQUISITES
Technologists, Technicians, Laboratory Managers
There are no participant prerequisites for this activity.

 

Enter Course

LEARNING OBJECTIVES
At the conclusion of this activity, participants should be able to:

  1. Understand the concept of pathogen inactivation/reduction.
  2. Discuss the measures taken to prevent transfusion-transmitted diseases.
  3. List the residual infectious risks from blood transfusions.
  4. Recall the results of the SPRINT study of transfusion of apheresis platelets that have been pathogen-reduced.
  5. Describe the systems for pathogen reduction of platelets and plasma.
  6. Discuss the FDA position on pathogen reduction.
  7. Review the highlights from the AABB Symposium on the implementation of pathogen-reduced blood components.
  8. Discuss the future of pathogen-reduced plasma and platelets.

LEARNING TASKS
To receive CEU credit for this activity, participants must:

  1. Review the presentation "An introduction to Pathogen Reduction" or review the slides and accompanying notes available as a printable Adobe Reader® file.
  2. Take the online Post-Test.
  3. Complete the online Activity Evaluation.
  4. Print the certificate awarding 1.0 AMA PRA Category 1 credit(s)TM through the SUCCESSTM program.

FACULTY
Jorge Rios, MD
Medical Director
Biomedical Services American Red Cross, Massahussetts Region
Dedham, MA

ACTIVITY PLANNER
Jorge Rios, MD
Medical Director
Biomedical Services American Red Cross, Massachussetts Region
Dedham MA


LEARNING REFERENCES

Listed in the presentation.

DISCLOSURES
Activity faculty and planners have indicated that they have no relevant financial relationships with commercial interests to disclose. No commercial support was received for this activity.

DISCLAIMER
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the American Red Cross Biomedical Services. Information herein is presented for educational purposes only and not to endorse off-label use. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

DESIGNATION STATEMENT
The American Red Cross Biomedical Services designates this educational activity for a maximum of 1.0 SUCCESS CEU; students should only claim credit commensurate with the extent of their participation in the activity.

PASSING REQUIREMENTS
If you correctly answer 70% or more of the post-test items you may claim credit.

DISCLOSURE STATEMENT
All faculty participating in ARCBS continuing education programs are expected to disclose to learners whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s); faculty are also expected to disclose off-label and/or investigational uses of products under discussion.

RELEASE DATE: 08/22/2016

EXPIRATION DATE: 08/21/2019

ESTIMATED TIME TO COMPLETE ACTIVITY: 1.0 hour(s)

Last modified: Thursday, August 9, 2018, 03:06 PM